About Heptatis BB Vaccine IP
Presenting the Heptatis BB Vaccine IP, a stellar advancement in immunization by BB Pharmaceuticals Pvt. Ltd., India. This opulent, yeast-derived recombinant vaccine guarantees triumphant protection against Hepatitis B infection for all ages. With its clear, colorless to slightly opalescent solution, each vial contains a carefully balanced dose, preserved with Thiomersal. Our reduced, advance purchase options secure the best price, ensuring access for every patient. Administered intramuscularly as prescribed, Heptatis BB Vaccine IP serves as a robust prophylactic to guard newborns, children, and adults against all known subtypes of Hepatitis B virus.
Heptatis BB Vaccine IP: Special Features & Indications
Heptatis BB Vaccine IP is meticulously crafted for the prevention of Hepatitis B in newborns, children, and adults. Featuring recombinant Hepatitis B surface antigen, it is suitable for all ages and delivered intramuscularly for maximum efficacy. The vaccine's opulent clarity and stability are maintained with Thiomersal as a preservative. Provided in single-use vials with sterile syringes, the product ensures safe and effective immunization, with dosage tailored as per physician guidelines for optimal results.
Certifications, Payment Terms, and Export Advantages
Heptatis BB Vaccine IP is certified to comply with stringent Indian pharmaceutical standards, assuring stellar quality and safety. We offer flexible payment terms to accommodate buyers globally and facilitate prompt, freight-efficient, and secure shipping via reliable channels. Our packaging ensures product potency during transit. Heptatis BB Vaccine IP is in demand across major export markets, including Asia, Africa, and the Middle East. Advance purchase options further support cost-efficient distribution for international suppliers and traders.
FAQ's of Heptatis BB Vaccine IP:
Q: How should Heptatis BB Vaccine IP be administered?
A: It should be administered intramuscularly, as per the immunization schedule and dosage prescribed by a physician. For children, 0.5 ml is recommended, while adults generally require 1 ml.
Q: What are the benefits of advance purchase for Heptatis BB Vaccine IP?
A: Advance purchase secures a reduced, best price for the vaccine and ensures timely availability, facilitating protection against Hepatitis B without supply delays.
Q: When is Heptatis BB Vaccine IP contraindicated?
A: This vaccine should not be administered to individuals with known hypersensitivity to any component of the vaccine, including the recombinant Hepatitis B surface antigen or Thiomersal.
Q: What side effects may occur after vaccination?
A: Common side effects include mild fever, soreness at the injection site, and general fatigue, which are generally transient and resolve without intervention.
Q: Where should Heptatis BB Vaccine IP be stored?
A: The vaccine must be stored at 2C to 8C and should not be frozen to maintain its efficacy and safety.
Q: What is the primary purpose of Heptatis BB Vaccine IP?
A: Heptatis BB Vaccine IP is intended for active immunization against all known subtypes of Hepatitis B virus, offering protection to newborns, children, adults, and the elderly.